Recruitment

Recruitment Status
Completed

Inclusion Criterias

Previously randomised into study TG002, completed all treatment visits and PTC during calendar year 2012.
Previously randomised into study TG002, completed all treatment visits and PTC during calendar year 2012.

Exclusion Criterias

Treatment with beta-blockers, alpha-adrenoreceptor blockers, tranquilizers or psychoactive drugs
"Partly controlled" and "uncontrolled" asthma
Subjects who cannot tolerate allergen challenge in the EEC
...
Treatment with beta-blockers, alpha-adrenoreceptor blockers, tranquilizers or psychoactive drugs
"Partly controlled" and "uncontrolled" asthma
Subjects who cannot tolerate allergen challenge in the EEC
Symptoms of a clinically relevant illness
History of anaphylaxis to grass allergen
FEV1 <80% of predicted.

Summary

Conditions
  • Grass Allergy
  • Rhinoconjunctivitis
Type
Observational
Design
  • Observational Model: Cohort
  • Time Perspective: Prospective

Participation Requirements

Age
Between 18 years and 65 years
Gender
Both males and females

Description

Subjects who completed all dosing visits and the post treatment challenge (PTC) in study TG002 will be invited to attend the Screening Visit for TG002a. Subjects will attend for 4 visits to the EEU on successive days. Following the last EEC visit a follow-up visit will be performed 3-10 days later.

Subjects who completed all dosing visits and the post treatment challenge (PTC) in study TG002 will be invited to attend the Screening Visit for TG002a. Subjects will attend for 4 visits to the EEU on successive days. Following the last EEC visit a follow-up visit will be performed 3-10 days later.

Inclusion Criterias

Previously randomised into study TG002, completed all treatment visits and PTC during calendar year 2012.
Previously randomised into study TG002, completed all treatment visits and PTC during calendar year 2012.

Exclusion Criterias

Treatment with beta-blockers, alpha-adrenoreceptor blockers, tranquilizers or psychoactive drugs
"Partly controlled" and "uncontrolled" asthma
Subjects who cannot tolerate allergen challenge in the EEC
...
Treatment with beta-blockers, alpha-adrenoreceptor blockers, tranquilizers or psychoactive drugs
"Partly controlled" and "uncontrolled" asthma
Subjects who cannot tolerate allergen challenge in the EEC
Symptoms of a clinically relevant illness
History of anaphylaxis to grass allergen
FEV1 <80% of predicted.

Tracking Information

NCT #
NCT01923779
Collaborators
  • Adiga Life Sciences, Inc.
  • Pharm-Olam International
Investigators
Not Provided